SAMHSA Notice To Opioid Treatment Programs About Drug Enforcement Administration Authorization For Mobile Components
On September 29, 2021, the U.S. Substance Abuse and Mental Health Ervices Administration (SAMHSA) published this notice to opioid treatment programs about Drug Enforcement Administration (DEA) authorization for mobile components. This document revises and supersedes related portions of SAMHSA’s 2015 Federal Guidelines for Opioid Treatment Programs (Guidelines) by clarifying the range of services that can be provided in both mobile and non-mobile medication units . . .
